Clinical Trial

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

Name: DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating — clinical trial record (NCT02487550)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal cell carcinoma, and to evaluate the clinical effect of the regimen.

Trial Details

NCT Number	NCT02487550
Lead Sponsor	The First People's Hospital of Changzhou
Conditions	Renal Neoplasma
Enrollment	1,200 participants
Start Date	2015-08
Primary Completion	2028-07 (estimated)
Study Completion	2030-07 (estimated)
Updated on ClinicalTrials.gov	2015-07-01